AR and prostate carcinoma: Given the reduced AR protein expression in sarcomatoid tumors and that the castrate DKO mice all had sarcomatoid pathology, it is likely that the rapid onset of castrate-resistant tumor growth was due to the progression of the prostate cancer to a sarcomatoid pathology.